Oct 16, 2026 04:15PM
Oct 12, 2026 07:01AM
Oct 12, 2026 07:00AM
Oct 7, 2026 07:05AM
Oct 7, 2026 07:05AM
Oct 6, 2026 07:05AM
Oct 6, 2026 07:05AM Zenas BioPharma to Host Virtual R&D Event
Sep 22, 2026 07:05AM
Sep 22, 2026 07:05AM
Sep 18, 2026 04:15PM
Sep 8, 2026 07:05AM
Sep 4, 2026 07:05AM
Aug 18, 2026 04:15PM
Aug 13, 2026 07:00AM Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Jul 17, 2026 04:15PM
Jun 17, 2026 04:15PM
Jun 11, 2026 04:15PM
Jun 2, 2026 07:05PM
Jun 2, 2026 07:05PM
May 28, 2026 07:05AM
May 19, 2026 07:05AM Zenas BioPharma to present phase 3 trial results at EULAR 2026
May 19, 2026 07:05AM
May 18, 2026 04:15PM
May 13, 2026 06:50AM
May 13, 2026 06:50AM
May 13, 2026 06:00AM
Apr 17, 2026 04:15PM
Mar 27, 2026 12:13AM Zenas BioPharma prices $300 million dual offering of notes and stock
Mar 27, 2026 12:12AM
Mar 26, 2026 04:01PM
Mar 26, 2026 04:01PM
Mar 16, 2026 06:01PM
Mar 16, 2026 07:00AM
Feb 20, 2026 04:15PM
Feb 9, 2026 07:05AM Zenas BioPharma drug meets primary endpoint in multiple sclerosis trial
Feb 9, 2026 07:05AM
Feb 4, 2026 07:05AM
Jan 16, 2026 04:15PM
Jan 5, 2026 07:05AM
Jan 5, 2026 07:05AM
Dec 19, 2025 04:15PM
Dec 15, 2025 07:05AM InnoCare drug meets primary goal in lupus trial for Zenas partner
Dec 15, 2025 07:05AM
Nov 12, 2025 07:05AM
Nov 11, 2025 07:05AM
Oct 27, 2025 07:05AM
Oct 27, 2025 07:05AM
Oct 8, 2025 05:00AM
Oct 8, 2025 05:00AM Zenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase 3 Development for Multip
Sep 2, 2025 07:15AM

1,199,226 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All